Literature DB >> 16949044

Characterization of oxidation end product of plasma albumin 'in vivo'.

Luca Musante1, Maurizio Bruschi, Giovanni Candiano, Andrea Petretto, Nazzareno Dimasi, Piero Del Boccio, Andrea Urbani, Giovanni Rialdi, Gian Marco Ghiggeri.   

Abstract

Anti-oxidants are paradoxically much lower in plasma than inside cells even blood is comparably exposed to the oxidative stress. 'In vitro' models suggest a critical role of albumin as substitutive anti-oxidant in plasma but no proof for this role is available 'in vivo.' Herein, we demonstrate by LC/MS/MS that plasma albumin undergoes massive oxidation in primary nephrotic syndrome, involving stable sulphonation SO3- of the free SH of Cys 34 with +48Da increase in exact mass of the protein (ESI-MS) and formation of a fast moving isoform in the pH range between 5 and 7. Physical-chemical experiments with DSC and fluorescence spectra indicate a thermal stabilization of the structure upon oxidation. This is the first demonstration of massive oxidation of albumin 'in vivo' that reflects a functional role of the protein. Free radicals should be implicated in the pathogenesis of proteinuria in human FSGS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949044     DOI: 10.1016/j.bbrc.2006.08.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Role of albumin and its modifications in glomerular injury.

Authors:  Shipra Agrawal; William E Smoyer
Journal:  Pflugers Arch       Date:  2017-07-22       Impact factor: 3.657

2.  Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome.

Authors:  R Bertelli; M Bodria; M Nobile; S Alloisio; R Barbieri; G Montobbio; P Patrone; G M Ghiggeri
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

3.  HPLC separation of human serum albumin isoforms based on their isoelectric points.

Authors:  Lucía Turell; Horacio Botti; Lucía Bonilla; María José Torres; Francisco Schopfer; Bruce A Freeman; Larissa Armas; Alejandro Ricciardi; Beatriz Alvarez; Rafael Radi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-20       Impact factor: 3.205

Review 4.  The thiol pool in human plasma: the central contribution of albumin to redox processes.

Authors:  Lucía Turell; Rafael Radi; Beatriz Alvarez
Journal:  Free Radic Biol Med       Date:  2013-06-07       Impact factor: 7.376

5.  Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome.

Authors:  R Bertelli; A Trivelli; A Magnasco; M Cioni; M Bodria; A Carrea; G Montobbio; G Barbano; G M Ghiggeri
Journal:  Clin Exp Immunol       Date:  2010-05-19       Impact factor: 4.330

6.  Electron Pathways through Erythrocyte Plasma Membrane in Human Physiology and Pathology: Potential Redox Biomarker?

Authors:  Elena Matteucci; Ottavio Giampietro
Journal:  Biomark Insights       Date:  2007-09-17

7.  LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity.

Authors:  Roberta Bertelli; Armando Di Donato; Michela Cioni; Fabio Grassi; Masami Ikehata; Alice Bonanni; Maria Pia Rastaldi; Gian Marco Ghiggeri
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

8.  Albumin antioxidant response to stress in diabetic nephropathy progression.

Authors:  Rafael Medina-Navarro; Itzia Corona-Candelas; Saúl Barajas-González; Margarita Díaz-Flores; Genoveva Durán-Reyes
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

9.  Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression.

Authors:  Lisa Pasterk; Sandra Lemesch; Bettina Leber; Markus Trieb; Sanja Curcic; Vanessa Stadlbauer; Rufina Schuligoi; Rudolf Schicho; Akos Heinemann; Gunther Marsche
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

10.  The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors.

Authors:  Veronika Binder; Senka Ljubojevic; Johannes Haybaeck; Michael Holzer; Dalia El-Gamal; Rudolf Schicho; Burkert Pieske; Akos Heinemann; Gunther Marsche
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-14       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.